386 related articles for article (PubMed ID: 10021302)
1. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients.
Cohen I; Figer A; Tepper R; Shapira J; Altaras MM; Yigael D; Beyth Y
Gynecol Oncol; 1999 Feb; 72(2):202-7. PubMed ID: 10021302
[TBL] [Abstract][Full Text] [Related]
2. Ovarian cyst formation in patients using tamoxifen for breast cancer.
Metindir J; Aslan S; Bilir G
Jpn J Clin Oncol; 2005 Oct; 35(10):607-11. PubMed ID: 16254040
[TBL] [Abstract][Full Text] [Related]
3. Ovarian cysts in tamoxifen-treated women with breast cancer.
Inal MM; Incebiyik A; Sanci M; Yildirim Y; Polat M; Pilanci B; Nayki C; Camuzcuoğlu H
Eur J Obstet Gynecol Reprod Biol; 2005 May; 120(1):104-6. PubMed ID: 15866095
[TBL] [Abstract][Full Text] [Related]
4. Successful co-treatment with LHRH-agonist for ovarian over-stimulation and cystic formation in premenopausal tamoxifen exposure.
Cohen I; Tepper R; Figer A; Flex D; Shapira J; Beyth Y
Breast Cancer Res Treat; 1999 May; 55(2):119-25. PubMed ID: 10481939
[TBL] [Abstract][Full Text] [Related]
5. Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen.
Ravdin PM; Fritz NF; Tormey DC; Jordan VC
Cancer Res; 1988 Feb; 48(4):1026-9. PubMed ID: 3123050
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cysts during tamoxifen use may affect the prognostic markers of premenopausal breast cancer.
Han W; Kim H; Ku SY; Kim SH; Choi YM; Kim JG; Moon SY
Gynecol Endocrinol; 2013 Jan; 29(1):16-9. PubMed ID: 22812679
[TBL] [Abstract][Full Text] [Related]
7. Ovarian cysts in women receiving tamoxifen for breast cancer.
Mourits MJ; de Vries EG; Willemse PH; ten Hoor KA; Hollema H; Sluiter WJ; de Bruijn HW; van der Zee AG
Br J Cancer; 1999 Apr; 79(11-12):1761-4. PubMed ID: 10206289
[TBL] [Abstract][Full Text] [Related]
8. [Menstrual abnormality in patients with breast cancer receiving adjuvant endocrine-chemotherapy].
Yasumura T; Oka T; Honjo H; Okada H
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2947-52. PubMed ID: 3140733
[TBL] [Abstract][Full Text] [Related]
9. Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer.
Partridge AH; Ruddy KJ; Gelber S; Schapira L; Abusief M; Meyer M; Ginsburg E
Fertil Steril; 2010 Jul; 94(2):638-44. PubMed ID: 19409543
[TBL] [Abstract][Full Text] [Related]
10. A prospective prognostic study of the hormonal milieu at the time of surgery in premenopausal breast carcinoma.
Pujol P; Daures JP; Brouillet JP; Chang S; Rouanet P; Bringer J; Grenier J; Maudelonde T
Cancer; 2001 May; 91(10):1854-61. PubMed ID: 11346866
[TBL] [Abstract][Full Text] [Related]
11. Antiestrogen-induced remissions in premenopausal women with stage IV breast cancer: effects on ovarian function.
Manni A; Pearson OH
Cancer Treat Rep; 1980; 64(6-7):779-85. PubMed ID: 6775808
[TBL] [Abstract][Full Text] [Related]
12. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
13. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
14. Endocrine effects of adjuvant letrozole + triptorelin compared with tamoxifen + triptorelin in premenopausal patients with early breast cancer.
Rossi E; Morabito A; De Maio E; Di Rella F; Esposito G; Gravina A; Labonia V; Landi G; Nuzzo F; Pacilio C; Piccirillo MC; D'Aiuto G; D'Aiuto M; Rinaldo M; Botti G; Gallo C; Perrone F; de Matteis A
J Clin Oncol; 2008 Jan; 26(2):264-70. PubMed ID: 18086795
[TBL] [Abstract][Full Text] [Related]
15. The effects of a low-fat/high-fiber diet on sex hormone levels and menstrual cycling in premenopausal women: a 12-month randomized trial (the diet and hormone study).
Gann PH; Chatterton RT; Gapstur SM; Liu K; Garside D; Giovanazzi S; Thedford K; Van Horn L
Cancer; 2003 Nov; 98(9):1870-9. PubMed ID: 14584069
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of radiotherapy for ovarian ablation: results of a breast intergroup study.
Hughes LL; Gray RJ; Solin LJ; Robert NJ; Martino S; Tripathy D; Ingle JN; Wood WC; ; ; ;
Cancer; 2004 Sep; 101(5):969-72. PubMed ID: 15329905
[TBL] [Abstract][Full Text] [Related]
17. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
18. Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma.
Sawka CA; Pritchard KI; Paterson AH; Sutherland DJ; Thomson DB; Shelley WE; Myers RE; Mobbs BG; Malkin A; Meakin JW
Cancer Res; 1986 Jun; 46(6):3152-6. PubMed ID: 3084082
[TBL] [Abstract][Full Text] [Related]
19. Ovarian histopathology in breast cancer patients receiving tamoxifen.
McGonigle KF; Vasilev SA; Odom-Maryon T; Simpson JF
Gynecol Oncol; 1999 Jun; 73(3):402-6. PubMed ID: 10366467
[TBL] [Abstract][Full Text] [Related]
20. Indication of hysteroscopy in tamoxifen treated breast cancer patients.
Taponeco F; Curcio C; Fasciani A; Giuntini A; Artini PG; Fornaciari G; Petraglia F; Genazzani AR
J Exp Clin Cancer Res; 2002 Mar; 21(1):37-43. PubMed ID: 12071527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]